Navi Medical Technologies
PrivateLast Round
Early Funding
Jul 28, 2026
Total Funding Raised
$5.9M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Navi Medical Technologies operates in Healthcare & Life Sciences and is based in Melbourne. Its latest recorded funding round was an Early Funding round in July 2026.
Navi Medical Technologies is a medical device company that develops the Neonav ECG Tip Location System to improve the safety and accuracy of central venous catheter placement in newborns and pediatric patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Navi Medical Technologies Comparables
Compare Navi Medical Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Piccolo Medical | 83% | |
| Spectrum Vascular | 77% | |
| pfm medical gmbh | 77% |
For institutional investors. Book with your work email.
Navi Medical Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jul 28, 2026 | ||||
| VC Round | Aug 2, 2023 | ||||
| Series A | Jun 1, 2022 | ||||
| Grant | Jan 21, 2020 | ||||
| Accelerator | Jul 7, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Navi Medical Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Victoria | Early Funding |
| The Actuator | VC Round, Accelerator |
| Artesian | VC Round, Series A |
| Australian Government | VC Round |
| Australian Government Department of Industry, Science and Resources | Series A, Grant |
| Pacific Channel | Early Funding |
| Karst Peak Rx | Early Funding |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 28, 2026
Open roles increased to 4, 5x the trailing average.
- Jul 28, 2026
Raised $4.7M led by Karst Peak Rx
For institutional investors. Book with your work email.
Navi Medical Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Navi Medical Technologies's valuation, stock price, and market status.
Is Navi Medical Technologies a public or private company?
Navi Medical Technologies is a private company.
What is the current stock price of Navi Medical Technologies?
Navi Medical Technologies is a private company, so its shares have no public market price. Caplight tracks Navi Medical Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Navi Medical Technologies worth (valuation)?
Valuation information for Navi Medical Technologies is not publicly available.
Can I buy Navi Medical Technologies stock?
Navi Medical Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Navi Medical Technologies's last funding round?
Navi Medical Technologies's most recent funding round was Early Funding on July 28, 2026.
Who are the main investors in Navi Medical Technologies?
Key investors in Navi Medical Technologies include Karst Peak Rx, Breakthrough Victoria.
Will Navi Medical Technologies IPO soon?
No public IPO plans have been announced for Navi Medical Technologies.
How can I track Navi Medical Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Navi Medical Technologies's shares on secondary markets.